Optimal dengue vaccination strategies of seropositive individuals

• Published in: Mathematical biosciences and engineering : MBE Vol. 16; no. 3; pp. 1171 - 1189
• Main Author: Shim, Eunha
• Format: Journal Article
• Language: English
• Published: United States AIMS Press 01.01.2019
• Subjects: Antibodies, Viral - blood; Antibodies, Viral - immunology; Calibration; cyd-tdv; Dengue - blood; Dengue - epidemiology; Dengue - prevention & control; Dengue Vaccines - therapeutic use; Dengue Virus; dengue; vaccine; Humans; Immunization Programs - standards; Incidence; mathematical model; Mexico - epidemiology; Models, Theoretical; optimal control; Risk; Serogroup; seropositive; Vaccination - methods; Mexico; mathematical model; optimal control; seropositive; vaccine; CYD-TDV; dengue
• ISSN: 1547-1063; 1551-0018; 1551-0018
• DOI: 10.3934/mbe.2019056

The dengue vaccine, CYD-TDV (Dengvaxia), has been licensed in 20 countries in Latin America and Southeast Asia beginning in 2015. In April 2018, the World Health Organization (WHO) advised that CYD-TDV should only be administered to individuals with a history of previous dengue virus infection. Usin...